These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3162625)

  • 1. 4-Demethoxydaunorubicin administered orally in advanced breast cancer. A phase II study.
    De Lena M; Brandi M; Bozzi D; Calabrese P; Romito S
    Tumori; 1988 Feb; 74(1):65-70. PubMed ID: 3162625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancer.
    Martoni A; Pacciarini MA; Pannuti F
    Eur J Cancer Clin Oncol; 1985 Jul; 21(7):803-6. PubMed ID: 3862582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new anthracycline 4-demethoxydaunorubicin by oral route in advanced pretreated breast cancer and melanoma. A pilot study.
    Martoni A; Pacciarini MA; Pannuti F
    Drugs Exp Clin Res; 1985; 11(2):127-31. PubMed ID: 3915281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of oral 4-demethoxydaunorubicin in previously treated (except anthracyclines) metastatic breast cancer patients.
    Kolarić K; Mechl Z; Potrebica V; Sopkova B
    Oncology; 1987; 44(2):82-6. PubMed ID: 3472133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial with oral idarubicin in advanced breast cancer.
    Lopez M; Di Lauro L; Papaldo P; Lazzaro B; Ganzina F; Di Pietro N
    Invest New Drugs; 1986; 4(1):39-42. PubMed ID: 3457780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer.
    Stuart NS; Cullen MH; Priestman TJ; Blackledge GR; Tyrrell CJ
    Cancer Chemother Pharmacol; 1988; 21(4):351-4. PubMed ID: 3163529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous administration of cyclophosphamide, methotrexate and 5-fluorouracil in metastatic breast cancer. A pilot study.
    De Lena M; Brandi M; Logroscino A; Lorusso V; Paradiso A; Maiello E
    Tumori; 1988 Feb; 74(1):57-63. PubMed ID: 3162624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous and oral demethoxydaunorubicin (NSC 256-439) in the treatment of acute leukemia and lymphoma: a pilot study.
    Eridani S; Slater NG; Singh AK; Pearson TC
    Blut; 1985 Jun; 50(6):369-72. PubMed ID: 3859341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies.
    Ganzina F; Pacciarini MA; Di Pietro N
    Invest New Drugs; 1986; 4(1):85-105. PubMed ID: 3516918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer.
    Berman E; Wittes RE; Leyland-Jones B; Casper ES; Gralla RJ; Howard J; Williams L; Baratz R; Young CW
    Cancer Res; 1983 Dec; 43(12 Pt 1):6096-101. PubMed ID: 6580068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy with 5-fluorouracil, oral Idarubicin, and cyclophosphamide (FIC) in metastatic breast cancer--an open phase II study.
    Kolarić K; Potrebica V; Vukas D; Mechl Z; Sopkova B
    J Cancer Res Clin Oncol; 1988; 114(3):301-5. PubMed ID: 3164312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of idarubicin given orally in the treatment of anthracycline-naive advanced breast cancer patients.
    Bastholt L; Dalmark M
    Cancer Treat Rep; 1987 May; 71(5):451-4. PubMed ID: 3471329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of oral weekly 4-demethoxydaunorubicin in advanced breast cancer.
    Smith DB; Howell A
    Eur J Cancer Clin Oncol; 1987 Apr; 23(4):391-4. PubMed ID: 3475204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical evaluation of oral and intravenous 4-demethoxydaunorubicin.
    Kavanagh JJ; Yeung KY; Savaraj N; Krakoff IH
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1187-9. PubMed ID: 3865774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients.
    Toffoli G; Sorio R; Aita P; Crivellari D; Corona G; Bearz A; Robieux I; Colussi AM; Stocco F; Boiocchi M
    Clin Cancer Res; 2000 Jun; 6(6):2279-87. PubMed ID: 10873078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma.
    Chisesi T; Capnist G; de Dominicis E; Dini E
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):681-4. PubMed ID: 3164269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral idarubicin in non-Hodgkin's lymphomas.
    Lopez M; Di Lauro L; Papaldo P
    Invest New Drugs; 1986; 4(3):263-7. PubMed ID: 3469170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase-II trial of 4-demethoxydaunorubicin (DMDR) for advanced hypernephroma.
    Scher HI; Yagoda A; Ahmed T; Budman D; Sordillo P; Watson RC
    Cancer Chemother Pharmacol; 1985; 14(1):79-80. PubMed ID: 3855289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
    Kris MG; Gralla RJ; Kelsen DP; Casper ES; Burke MT; Fiore JJ; Cibas IR; Heelan RT
    Am J Clin Oncol; 1985 Oct; 8(5):377-9. PubMed ID: 3864366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose oral administration of 4-demethoxydaunorubicin (idarubicin) in advanced cancer patients. A pharmacokinetic study.
    Pannuti F; Camaggi CM; Strocchi E; Comparsi R; Angelelli B; Pacciarini MA
    Cancer Chemother Pharmacol; 1986; 16(3):295-9. PubMed ID: 3457647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.